Laurus Labs Limited
LAURUSLABS
Classificação em ações
#1744
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Preço da ação
$22.80
Valor de mercado
$12.32B
Variação (1 dia)
0.36%
Variação (1 ano)
122.99%
País
IN
Negociar Laurus Labs Limited (LAURUSLABS)
Categoria
Healthcare
EPS de Laurus Labs Limited (LAURUSLABS)
EPS em June 2026 TTM: $0.22
De acordo com os últimos relatórios financeiros e o preço das ações da Laurus Labs Limited, o EPS atual da empresa (TTM) é $0.22. No final de 2024, a empresa teve um EPS de $0.04, uma diminuição em relação a ao EPS de 2023, que foi de $0.18.
Histórico de EPS da Laurus Labs Limited de 2013 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $0.22 | 179.38% |
| 2025 | $0.08 | 117.93% |
| 2024 | $0.04 | -80.03% |
| 2023 | $0.18 | -11.96% |
| 2022 | $0.20 | -19.02% |
| 2021 | $0.25 | 294.34% |
| 2020 | $0.06 | 149.41% |
| 2019 | $0.03 | -47.64% |
| 2018 | $0.05 | -24.02% |
| 2017 | $0.06 | -0.62% |
| 2016 | $0.06 | 82.20% |
| 2015 | $0.04 | -4.07% |
| 2014 | $0.04 | -30.64% |
| 2013 | $0.05 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 148.90% |
IN
|
